Source: Investing.com ↗

H.C. Wainwright reiterates Lyell Immunopharma stock rating at buy

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.02%

BTC/USDT

$85,748.77

-0.14%

ETH/USDT

$2,731.34

-0.30%

ZEC/USDT

$1,642.80

+9.88%

XRP/USDT

$1.59

+4.59%